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Abstract
Introduction: The rapid rise in electronic cigarettes (ECs) globally has stimulated much debate about 
the relative risk and public health impact of this new emerging product category as compared to con-
ventional cigarettes. The sale and marketing of ECs containing nicotine are banned in many countries 
(eg, Australia) but are allowed in others (eg, United Kingdom). This study examined prevalence and 
correlates of the belief that ECs are a lot less harmful than conventional cigarettes under the different 
regulatory environments in Australia (ie, more restrictive) and the United Kingdom (ie, less restrictive).
Methods: Australian and UK data from the 2013 survey of the International Tobacco Control Four-
Country project were analyzed.
Results: More UK than Australian respondents (58.5% vs. 35.2%) believed that ECs are a lot less 
harmful than conventional cigarettes but more respondents in Australia than in the United Kingdom 
selected “Don’t Know” (36.5% vs. 17.1%). The proportion that responded “A little less, equally or 
more harmful” did not differ between countries. Correlates of the belief that ECs are “A lot less 
harmful” differed between countries, while correlates of “Don’t Know” response did not differ.
Conclusions: Consistent with the less restrictive regulatory environment affecting the sale and 
marketing of ECs, smokers and recent ex-smokers in the United Kingdom were more likely to 
believe ECs were less harmful relative to conventional cigarettes compared to those in Australia.
Implications: What this study adds: Among smokers and ex-smokers, this study found that the 
belief that ECs are (a lot) less harmful than conventional cigarettes was considerably higher in the 
United Kingdom than in Australia in 2013. The finding is consistent with the less restrictive regula-
tory environment for ECs in the United Kingdom, suggesting that the regulatory framework for ECs 
adopted by a country can affect smokers’ perceptions about the relative harmfulness of ECs, the 
group that stands to gain the most from having an accurate belief about the relative harms of ECs.
 Nicotine & Tobacco Research Advance Access published August 8, 2016
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Introduction
Use of electronic cigarettes (ECs) has risen rapidly in recent years1–3 
and this has fuelled debate in the public health community on how 
to regulate ECs. In many countries, there are currently no specific 
laws that directly apply to ECs. This is the case in Australia where a 
number of existing laws relating to poisons, therapeutic goods and 
tobacco control apply to ECs in some circumstances. ECs containing 
nicotine cannot be legally sold without a permit or a doctor’s pre-
scription in Australia. However, non-nicotine containing ECs can be 
sold and used lawfully. However, in several states ECs are effectively 
banned under legislation prohibiting products that look like ciga-
rettes.4 Advertising of ECs is also effectively banned, although some 
exposure to advertising may still occur in Australia via the internet.
By contrast, in countries like the United Kingdom there are few 
restrictions on the marketing and sale of ECs. In May 2014 the EU 
tobacco products directive covering ECs came into force, which 
introduced controls on product characteristics, nicotine content, 
and labeling, and prohibited some types of EC marketing when sold 
as consumer goods. However, EU countries have until mid-2016 to 
implement the tobacco products directive. The UK Medicines and 
Healthcare Products Regulatory Agency (MHRA) has also encour-
aged EC manufacturers to apply for medicinal licences for their 
products to be approved as for nicotine replacement therapies; how-
ever few manufacturers have taken advantage of this opportunity 
with only one EC to date having been registered and approved,5 and 
no EC products are currently available for sale as licensed nicotine 
therapeutics. England is the first part of the United Kingdom, and 
also the first place in the world, to promote licensed nicotine-con-
taining products, including any licensed ECs, for harm reduction 
in line with guidance from the National Institute for Health Care 
Excellence (NICE).6 At the time this study was conducted, market-
ing of ECs in the United Kingdom was permitted, but under general 
advertising rules several EC ads had been banned for making mis-
leading claims.
The long-term health risks of EC use are unknown at this time, but 
compared with conventional cigarettes, ECs are almost certainly less 
harmful to users and bystanders.7–9 While the use of ECs is strongly 
predicted by risk perceptions in relation to conventional cigarettes,2,10,11 
the extent to which different regulatory environments might affect 
smokers’ beliefs about EC relative harmfulness is unknown. We 
would expect ECs to be considered safer than conventional cigarettes 
when the regulatory environment is less restrictive in regards to mar-
keting of ECs, as in the United Kingdom relative to Australia. In the 
United Kingdom, the marketing of ECs in the form of implicit and 
explicit claims via advertising of reduced harm for EC products and 
also by public endorsements of ECs from multiple respected health 
organizations (eg, Action on Smoking and Health,12,13 Royal College 
of Physicians14), are likely to have generated a more favorable public 
perception about EC risks and/or relative risks. Nevertheless, there are 
also public dis-endorsements (eg, British Medical Association15) and 
a number of popular media outlets have published articles warning 
that ECs and their emitted aerosols are dangerous.16 By contrast, the 
restrictions on EC marketing and retail sales in Australia combined 
with mainly public dis-endorsements of ECs from prominent health 
organizations (eg, Cancer Councils, National Health Foundation) and 
prominent tobacco control advocates are likely to create a perception 
that the products are harmful and thus, increase the perceived risk or 
uncertainties about the products.
This study (1) examines prevalence and correlates of beliefs about 
the relative harmfulness of ECs and conventional cigarettes among 
smokers and ex-smokers in Australia and the United Kingdom, 
and (2) determines whether these differed across the two countries. 
Insights gained from this comparative study are likely to be useful 
for informing other countries on policy with respect to ECs.
Methods
Sample and Data Collection Procedures
Data analyzed were from the Australian and United Kingdom 
(collected between February to May and February to September, 
2013, respectively) arm of the International Tobacco Control Four-
Country (ITC) project, a longitudinal cohort study of adult smokers 
followed up approximately yearly with replenishment of cases lost 
to the study (study design and sampling frames have been described 
elsewhere17,18). The Australian sample had significantly more par-
ticipants who were younger, of higher income and more addicted 
than the UK sample, but the two samples were otherwise similar 
(Supplementary Table 1).
Measures
EC awareness and trial were assessed using the questions “Have you 
ever heard of electronic cigarettes or e-cigarettes?” and “Have you 
ever tried an electronic cigarette?”, both answered Yes/No. Those who 
had tried were asked “How often, if at all, do you currently use an 
electronic cigarette?” with the response options “Daily, Less than daily, 
Less than weekly, Less than monthly or Not at all”. All participants 
aware of ECs were asked whether or not they thought ECs were more, 
less or equally harmful as regular cigarettes, with “Don’t Know” an 
acceptable response. Those who indicated that ECs were less harm-
ful were followed up with the question: “Are they a little or a lot less 
harmful than regular cigarettes?” An ordinal measure of perceived 
harmfulness of ECs relative to conventional cigarettes was derived 
(a dichotomized version was used for regression analysis where “A 
lot less harmful” vs. otherwise was also explored). Respondents were 
also asked about noticing EC adverts in the last 6 months along with 
standard sociodemographics and smoking-related variables.
Data Analysis
Prevalence estimates and 95% confidence intervals were computed 
for EC relative harmfulness beliefs among both smokers and ex-
smokers stratified by country. Correlates of the belief that ECs are 
(a lot) less harmful were examined using multiple logistic regression 
models and tested for country differences. Additional analyses were 
conducted to explore correlates of answering “Don’t Know” to the 
question of whether ECs are less harmful than conventional ciga-
rettes. All analyses were conducted using Stata v12.1.
Results
EC Risk Perceptions in Australia and the United 
Kingdom
Significantly more UK respondents than Australian respondents 
believed that ECs are a lot less harmful than conventional cigarettes 
(59% vs. 35%, adjusted odds ratio [AOR]  =  0.50, P < .001; see 
Table 1). Response patterns were otherwise similar, with the excep-
tion of “Don’t Know” responses. More Australian respondents than 
those in the United Kingdom answered “Don’t Know” when asked 
about the relative harmfulness of ECs (37% vs. 17%, AOR = 2.34, 
P < .001).
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Correlates of EC Risk Perceptions in Australia and 
the United Kingdom
Table 2 presents correlates of the belief that ECs are a lot less harm-
ful than conventional cigarettes (correlates of ECs being less harmful 
are similar, results not shown). Overall, this belief was more likely to 
be endorsed by respondents from the United Kingdom. In both coun-
tries, this belief was also more likely to be endorsed by those from an 
English-speaking background (effect significant only in Australia), 
those who had tried ECs before or were current users, and those 
who had noticed EC ads on the internet (significant only in the 
United Kingdom), but no effect was found for in-store advertising. 
Additional significant effects found in the United Kingdom but not in 
Australia included younger age and higher household income, both 
associated with greater odds of believing ECs to be a lot less harm-
ful. Gender, education and survey mode showed differential effects 
across countries (significant by-country interaction: P = .024, .045 
and .010, respectively). Australian respondents who were female and 
had been surveyed by phone were more likely to believe ECs to be a 
lot less harmful, whereas in the United Kingdom no gender or survey 
mode effects were found. Education was not a significant independ-
ent predictor in either country, but there were trends for higher edu-
cation in Australia and lower education in the United Kingdom to be 
associated with believing they were less harmful.
Correlates of reported uncertainty about EC relative harmfulness 
were similar in the two countries, though in the opposite direction to 
those for “A lot less harmful” belief. “Don’t Know” responses were 
more likely to be given by respondents from Australia, who had not 
tried ECs, who had not seen EC ads on the internet, those from older 
age groups, and web survey respondents. In addition, those who had 
quit for more than a year were less likely to respond “Don’t Know” 
than current smokers.
Discussion
The findings from this study show that smokers and ex-smokers 
in the United Kingdom are more likely than their counterparts in 
Australia to believe the almost certain fact that ECs are a lot less 
harmful than conventional cigarettes, but that there is more uncer-
tainty about relative harmfulness in Australia. This result is consist-
ent with the more permissive regulatory environment for ECs and 
the higher base rate of EC awareness and use observed in 2013 in the 
United Kingdom compared to Australia.2 The substantial expressed 
uncertainty about EC relative harmfulness observed in both coun-
tries is likely related to the ongoing public debate about the potential 
public health benefits and consequences of EC use.
The results also show that the characteristics of those who believe 
that ECs are a lot less harmful than conventional cigarettes are 
somewhat different in the two countries, suggesting that the type of 
regulatory environment is likely to affect who will hold such a view 
of EC relative risk profile. The mixed relationships between country 
and belief are hard to interpret. Some may reflect access to informa-
tion, extent of exposure to them and the extent of disinformation.
Consistent with past studies,2,10 there was a strong positive asso-
ciation between having tried ECs and believing them to be a lot less 
harmful than conventional cigarettes, suggesting that those who 
hold favorable beliefs about EC relative harmfulness are more will-
ing to try and/or continue to use ECs, and/or that trial prompts the 
search for information. By contrast, smokers from both countries 
who were uncertain about the relative harmfulness of ECs were less 
likely to have tried or to currently use ECs.
One key lesson from this study is that the regulatory frame-
work for ECs adopted by a country can affect perceptions about the 
harmfulness of ECs relative to conventional cigarettes among smok-
ers and ex-smokers. Jurisdictions with a more restrictive environ-
ment for ECs must recognize that misinformation and/or ignorance 
about EC relative risk in comparison to conventional cigarettes is 
likely substantial in their population, especially among subgroups 
who are not proactive in seeking out authoritative information. The 
high levels of public confusion and misinformation (64% and 42% 
of Australian and UK smokers, respectively, were misinformed in 
2013) need to be remedied by evidence-based public education to 
ensure that smokers can make informed choices about the potential 
Table 1. Prevalence Estimates of Relative Harmfulness Belief About Electronic Cigarettes (ECs) Among Smokers and Ex-Smokers Who 
Were Aware of ECs (Australia vs. the United Kingdom, 2013 Survey of the International Tobacco Control Four-Country Project)
Belief ECs as compared to conventional cigarettes
% (95% CI)
Smokers Quit ≤ 12 months Quit > 12 months Total
Australia
 N 695 73 148 916
 A lot less harmful 36.0 (31.2–41.2) 33.1 (21.3–47.5) 32.6 (23.4–43.5) 35.2 (31.1–39.6)
 Unsure how much less harmful 4.2 (2.6–6.7) 6.2 (2.5–14.6) 4.8 (2.4–9.1) 4.5 (3.1–6.4)
 A little less harmful 15.7 (11.3–21.4) 10.8 (4.5–23.9) 9.8 (4.8–18.9) 14.4 (10.8–18.9)
 Don’t know 36.3 (31.4–41.4) 41.8 (26.9–58.3) 34.9 (25.6–45.5) 36.5 (32.2–40.9)
 Equally harmful 7.3 (5.2–10.2) 8.0 (3.4–17.9) 17.8 (10.9–27.6) 9.1 (7.0–11.8)
 More harmful 0.4 (0.2–1.1) 0 0.2 (0.0–1.5) 0.4 (0.1–0.9)
United Kingdom
 N 987 73 209 1269
 A lot less harmful 57.6 (53.7–61.4) 72.4 (58.1–83.2) 57.2 (48.0–65.9) 58.5 (55.0–61.9)
 Unsure how much less harmful 3.3 (2.3–4.7) 1.7 (0.3–7.9) 3.2 (1.5–6.5) 3.2 (2.3–4.3)
 A little less harmful 11.8 (9.5–14.6) 9.1 (3.3–22.9) 16.7 (11.1–24.3) 12.4 (10.3–14.9)
 Don’t know 17.5 (14.8–20.5) 13.7 (7.4–23.9) 17.0 (12.1–23.4) 17.1 (14.8–19.8)
 Equally harmful 8.3 (6.5–10.6) 2.8 (0.9–8.8) 5.6 (2.9–10.6) 7.5 (6.0–9.4)
 More harmful 1.6 (0.8–3.1) 0.3 (0.0–2.4) 0.3 (0.0–2.2) 1.3 (0.7–2.5)
CI = confidence interval. Estimates are based on weighted data.
 at K
ing's College London - Journals D
ept on A
ugust 9, 2016
http://ntr.oxfordjournals.org/
D
ow
nloaded from
 
Nicotine & Tobacco Research, 2016, Vol. 00, No. 004
Ta
b
le
 2
. L
o
g
is
ti
c 
R
eg
re
ss
io
n
 R
es
u
lt
s 
S
h
o
w
in
g
 C
o
rr
el
at
es
 o
f 
th
e 
B
el
ie
f T
h
at
 E
C
s 
ar
e 
“A
 L
o
t 
Le
ss
 H
ar
m
fu
l,”
 a
n
d
 “
D
o
n’
t 
K
n
o
w
” 
R
es
p
o
n
se
s,
 in
 t
h
e 
U
n
it
ed
 K
in
g
d
o
m
 a
n
d
 A
u
st
ra
lia
, 2
01
3 
S
u
rv
ey
 
o
f 
th
e 
In
te
rn
at
io
n
al
 To
b
ac
co
 C
o
n
tr
o
l F
o
u
r-
C
o
u
n
tr
y 
Pr
o
je
ct
V
ar
ia
bl
es
B
el
ie
ve
d 
th
at
 E
C
s 
ar
e 
a 
lo
t 
le
ss
 h
ar
m
fu
l v
s.
 o
th
er
w
is
e
D
id
n’
t 
kn
ow
 w
he
th
er
 E
C
s 
ar
e 
le
ss
 h
ar
m
fu
l v
s.
 o
th
er
w
is
e
A
O
R
 (
95
%
 C
I)
A
O
R
 (
95
%
 C
I)
C
om
bi
ne
d:
 N
 =
 2
10
5
U
ni
te
d 
K
in
gd
om
: N
 =
 1
21
5
A
us
tr
al
ia
: N
 =
 8
90
C
om
bi
ne
d:
 N
 =
 2
10
5
U
ni
te
d 
K
in
gd
om
: N
 =
 1
21
5
A
us
tr
al
ia
: N
 =
 8
90
C
ou
nt
ry
 
U
ni
te
d 
K
in
gd
om
R
ef
—
—
R
ef
—
—
 
A
us
tr
al
ia
0.
50
 (
0.
41
–0
.6
1)
**
*
—
—
2.
34
 (
1.
87
–2
.9
4)
**
*
—
—
E
C
 u
se
 
N
ev
er
R
ef
R
ef
R
ef
R
ef
R
ef
R
ef
 
T
ri
ed
 b
ef
or
e
1.
77
 (
1.
40
–2
.2
4)
**
*
1.
91
 (
1.
41
–2
.6
0)
**
*
1.
72
 (
1.
18
–2
.5
0)
**
0.
47
 (
0.
35
–0
.6
2)
**
*
0.
38
 (
0.
25
–0
.5
9)
**
*
0.
52
 (
0.
34
–0
.7
8)
**
 
C
ur
re
nt
 u
se
2.
13
 (
1.
63
–2
.7
8)
**
*
2.
05
 (
1.
48
–2
.8
3)
**
*
2.
54
 (
1.
56
–4
.1
3)
**
*
0.
32
 (
0.
22
–0
.4
6)
**
*
0.
31
 (
0.
19
–0
.4
9)
**
*
0.
32
 (
0.
18
–0
.5
7)
**
*
N
ot
ic
ed
 E
C
 a
ds
 o
n 
th
e 
in
te
rn
et
 
N
o
R
ef
R
ef
R
ef
R
ef
R
ef
R
ef
 
Y
es
1.
38
 (
1.
11
–1
.7
3)
**
1.
33
 (
1.
01
–1
.7
5)
*
1.
44
 (
0.
98
–2
.1
1)
0.
61
 (
0.
47
–0
.8
1)
**
0.
63
 (
0.
43
–0
.9
2)
*
0.
62
 (
0.
40
–0
.9
5)
*
N
ot
ic
ed
 E
C
 a
ds
 in
si
de
 s
to
re
s
 
N
o
R
ef
R
ef
R
ef
R
ef
R
ef
R
ef
 
Y
es
1.
17
 (
0.
94
–1
.4
7)
1.
22
 (
0.
95
–1
.5
7)
1.
09
 (
0.
63
–1
.8
9)
0.
80
 (
0.
60
–1
.0
7)
0.
75
 (
0.
54
–1
.0
5)
0.
91
 (
0.
49
–1
.6
6)
Sm
ok
in
g 
st
at
us
 
Sm
ok
er
s
R
ef
R
ef
R
ef
R
ef
R
ef
R
ef
 
Q
ui
t 
≤ 
12
 m
on
th
s
1.
26
 (
0.
84
–1
.8
9)
1.
18
 (
0.
67
–2
.0
9)
1.
43
 (
0.
79
–1
.5
9)
0.
89
 (
0.
56
–1
.4
0)
1.
22
 (
0.
60
–2
.4
9)
0.
68
 (
0.
37
–1
.2
5)
 
Q
ui
t 
> 
12
 m
on
th
s
1.
10
 (
0.
80
–1
.5
1)
1.
15
 (
0.
76
–1
.7
4)
1.
03
 (
0.
62
–1
.7
3)
0.
64
 (
0.
46
–0
.9
1)
*
0.
65
 (
0.
38
–1
.0
9)
0.
61
 (
0.
37
–1
.0
2)
A
ge
 g
ro
up
 (
ye
ar
s)
 
18
–2
4
R
ef
R
ef
R
ef
R
ef
R
ef
R
ef
 
25
–3
9
0.
62
 (
0.
40
–0
.9
7)
*
0.
48
 (
0.
25
–0
.9
1)
*
0.
75
 (
0.
39
–1
.4
6)
2.
44
 (
1.
23
–4
.8
3)
*
4.
41
 (
1.
02
–1
9.
10
)*
2.
08
 (
0.
92
–4
.7
0)
 
40
–5
4
0.
81
 (
0.
53
–1
.2
6)
0.
71
 (
0.
38
–1
.3
4)
0.
87
 (
0.
46
–1
.6
6)
3.
39
 (
1.
74
–6
.6
1)
**
*
5.
05
 (
1.
18
–2
1.
50
)*
3.
21
 (
1.
46
–7
.1
0)
**
 
≥5
5
0.
63
 (
0.
40
–0
.9
8)
*
0.
45
 (
0.
24
–0
.8
6)
*
0.
92
 (
0.
46
–1
.8
5)
4.
38
 (
2.
21
–8
.6
6)
**
*
8.
66
 (
2.
02
–3
7.
15
)*
*
3.
03
 (
1.
32
–6
.9
5)
**
Se
x
 
M
al
e
R
ef
R
ef
R
ef
R
ef
R
ef
R
ef
 
Fe
m
al
e
1.
04
 (
0.
87
–1
.2
5)
0.
89
 (
0.
70
–1
.1
2)
1.
37
 (
1.
02
–1
.8
3)
*
1.
01
 (
0.
82
–1
.2
5)
1.
17
 (
0.
86
–1
.5
8)
0.
85
 (
0.
63
–1
.1
5)
E
du
ca
ti
on
 
L
ow
R
ef
R
ef
R
ef
R
ef
R
ef
R
ef
 
M
od
er
at
e
1.
02
 (
0.
82
–1
.2
6)
0.
82
 (
0.
62
–1
.1
0)
1.
37
 (
0.
98
–1
.9
0)
0.
89
 (
0.
70
–1
.1
4)
1.
13
 (
0.
78
–1
.6
3)
0.
74
 (
0.
52
–1
.0
3)
 
H
ig
h
0.
93
 (
0.
72
–1
.1
9)
0.
77
 (
0.
55
–1
.0
6)
1.
23
 (
0.
82
–1
.8
4)
0.
90
 (
0.
67
–1
.2
0)
1.
13
 (
0.
74
–1
.7
1)
0.
73
 (
0.
49
–1
.1
0)
In
co
m
e
 
L
ow
R
ef
R
ef
R
ef
R
ef
R
ef
R
ef
 
M
ed
iu
m
0.
97
 (
0.
76
–1
.2
4)
1.
01
 (
0.
74
–1
.3
6)
0.
90
 (
0.
59
–1
.3
8)
1.
01
 (
0.
77
–1
.3
4)
1.
11
 (
0.
76
–1
.6
1)
0.
89
 (
0.
58
–1
.3
6)
 
H
ig
h
1.
27
 (
0.
99
–1
.6
2)
1.
38
 (
1.
00
–1
.9
1)
*
1.
17
 (
0.
78
–1
.7
6)
0.
80
 (
0.
60
–1
.0
6)
0.
75
 (
0.
49
–1
.1
5)
0.
77
 (
0.
51
–1
.1
6)
 
N
o 
an
sw
er
0.
88
 (
0.
61
–1
.2
6)
0.
97
 (
0.
61
–1
.5
5)
0.
75
 (
0.
41
–1
.3
6)
1.
27
 (
0.
85
–1
.8
9)
1.
07
 (
0.
60
–1
.9
1)
1.
42
 (
0.
80
–2
.5
2)
 at K
ing's College London - Journals D
ept on A
ugust 9, 2016
http://ntr.oxfordjournals.org/
D
ow
nloaded from
 
Nicotine & Tobacco Research, 2016, Vol. 00, No. 00 5
V
ar
ia
bl
es
B
el
ie
ve
d 
th
at
 E
C
s 
ar
e 
a 
lo
t 
le
ss
 h
ar
m
fu
l v
s.
 o
th
er
w
is
e
D
id
n’
t 
kn
ow
 w
he
th
er
 E
C
s 
ar
e 
le
ss
 h
ar
m
fu
l v
s.
 o
th
er
w
is
e
A
O
R
 (
95
%
 C
I)
A
O
R
 (
95
%
 C
I)
C
om
bi
ne
d:
 N
 =
 2
10
5
U
ni
te
d 
K
in
gd
om
: N
 =
 1
21
5
A
us
tr
al
ia
: N
 =
 8
90
C
om
bi
ne
d:
 N
 =
 2
10
5
U
ni
te
d 
K
in
gd
om
: N
 =
 1
21
5
A
us
tr
al
ia
: N
 =
 8
90
M
in
or
it
y 
st
at
us
 
Sp
ok
e 
no
n-
E
ng
lis
h/
no
n-
w
hi
te
R
ef
R
ef
R
ef
R
ef
R
ef
R
ef
 
Sp
ok
e 
E
ng
lis
h 
on
ly
/w
hi
te
1.
66
 (
1.
17
–2
.3
5)
**
1.
41
 (
0.
87
–2
.2
9)
2.
06
 (
1.
19
–3
.5
7)
*
0.
70
 (
0.
48
–1
.0
3)
0.
63
 (
0.
34
–1
.1
6)
0.
76
 (
0.
46
–1
.2
6)
H
ea
vi
ne
ss
 o
f 
Sm
ok
in
g 
In
de
x#
1.
00
 (
0.
93
–1
.0
6)
0.
95
 (
0.
87
–1
.0
4)
1.
03
 (
0.
93
–1
.1
4)
0.
99
 (
0.
92
–1
.0
7)
1.
07
 (
0.
95
–1
.2
1)
0.
95
 (
0.
86
–1
.0
6)
W
av
e 
of
 r
ec
ru
it
m
en
t
1.
01
 (
0.
98
–1
.0
4)
0.
99
 (
0.
96
–1
.0
5)
1.
01
 (
0.
96
–1
.0
7)
0.
97
 (
0.
93
–1
.0
0)
0.
96
 (
0.
91
–1
.0
2)
0.
97
 (
0.
92
–1
.0
3)
Su
rv
ey
 m
od
e
 
W
eb
R
ef
R
ef
R
ef
R
ef
R
ef
R
ef
 
Ph
on
e
1.
21
 (
0.
99
–1
.4
7)
0.
97
 (
0.
75
–1
.2
5)
1.
64
 (
1.
20
–2
.2
2)
**
0.
51
 (
0.
41
–0
.6
4)
**
*
0.
72
 (
0.
51
–1
.0
0)
0.
37
 (
0.
27
–0
.5
1)
**
*
A
O
R
 =
 a
dj
us
te
d 
od
ds
 r
at
io
s;
 C
I 
= 
co
nfi
de
nc
e 
in
te
rv
al
; e
st
im
at
es
 a
dj
us
te
d 
fo
r 
va
ri
ab
le
s 
in
 t
he
 t
ab
le
; E
C
 =
 e
le
ct
ro
ni
c 
ci
ga
re
tt
e;
 #
 c
od
ed
 a
s 
ze
ro
 f
or
 e
x-
sm
ok
er
s.
*P
 <
 .0
5;
 *
*P
 <
 .0
1;
 *
**
P
 <
 .0
01
.
Ta
b
le
 2
. 
C
o
n
ti
n
u
ed
 at K
ing's College London - Journals D
ept on A
ugust 9, 2016
http://ntr.oxfordjournals.org/
D
ow
nloaded from
 
Nicotine & Tobacco Research, 2016, Vol. 00, No. 006
benefits of ECs to them, including an assessment of the risks. This is 
particularly important for smokers who are unable or unwilling to 
quit. It is unethical to resist informing current smokers of the poten-
tial benefits of switching to ECs by arguing that we do not know 
enough about the long-term risks of EC use, when we know almost 
certainly that ECs are considerably less harmful than conventional 
cigarettes.9
Several limitations warrant some discussion. First, because 
country and regulatory environment are confounded, some of the 
differences we attribute to the regulatory differences may be due 
to other country differences, including differences in publicly dis-
seminated messages from health authorities. Also, less harmful 
belief about ECs was related to age and income, two sample char-
acteristics that differed significantly between the two countries. 
However, the differences were in the direction that strengthens the 
findings, that is, the UK sample was less misinformed despite the 
fact that the respondents were older and less affluent. Given that 
the two countries are otherwise similar with regard to tobacco 
control policy and the fact that our models controlled for soci-
odemographic characteristics of participants, we consider the EC 
regulatory environment to be the most plausible explanation for 
the observed differences2 although contribution from dissimilar 
publicly disseminated messages about the potential risks of ECs 
from health authorities in the two countries could not be ruled out. 
Secondly, the cross-sectional findings here may not generalize over 
time as new product, new advertising standards and inaccurate 
media stories continue to appear. Thirdly, the observed country dif-
ferences may reflect some methodological artefacts such as survey 
mode although this is likely to be minimal as this was controlled 
for in our models.
Consistent with the divergent regulatory environments affect-
ing the sale and marketing of ECs in the two countries (ie, more 
restrictive in Australia and less restrictive in the United Kingdom) 
smokers and recent ex-smokers in the United Kingdom were more 
likely to believe ECs were less harmful relative to conventional ciga-
rettes compared to smokers in Australia. The substantial expressed 
uncertainty observed in both countries is likely a result of ongoing 
public debate and scientific uncertainty of the potential benefits and 
the feared negative consequences of increased EC use at the societal 
level. Public education, based on science, may be helpful to remedy 
this situation, in particular, to reduce the substantial number of mis-
informed smokers in both countries.
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